Hypereosinophilic syndrome presenting acutely with neurologic signs

Ann Allergy Asthma Immunol. 2018 May;120(5):461-464. doi: 10.1016/j.anai.2018.02.032. Epub 2018 Feb 28.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Arthralgia / diagnostic imaging
  • Arthralgia / drug therapy
  • Arthralgia / immunology
  • Arthralgia / physiopathology
  • Chronic Disease
  • Churg-Strauss Syndrome / diagnostic imaging
  • Churg-Strauss Syndrome / drug therapy
  • Churg-Strauss Syndrome / immunology
  • Churg-Strauss Syndrome / physiopathology
  • Cough / diagnostic imaging
  • Cough / drug therapy
  • Cough / immunology
  • Cough / physiopathology*
  • Diagnosis, Differential
  • Eosinophils / drug effects
  • Eosinophils / immunology
  • Eosinophils / pathology
  • Humans
  • Hypereosinophilic Syndrome / diagnostic imaging
  • Hypereosinophilic Syndrome / drug therapy
  • Hypereosinophilic Syndrome / immunology
  • Hypereosinophilic Syndrome / physiopathology*
  • Hypokinesia / diagnostic imaging
  • Hypokinesia / drug therapy
  • Hypokinesia / immunology
  • Hypokinesia / physiopathology
  • Magnetic Resonance Imaging
  • Male
  • Methylprednisolone Hemisuccinate / therapeutic use
  • Nasal Polyps / diagnostic imaging
  • Nasal Polyps / drug therapy
  • Nasal Polyps / immunology
  • Nasal Polyps / physiopathology*
  • Prednisone / therapeutic use
  • Rhinitis, Allergic / diagnostic imaging
  • Rhinitis, Allergic / drug therapy
  • Rhinitis, Allergic / immunology
  • Rhinitis, Allergic / physiopathology*
  • Thrombophilia / diagnostic imaging
  • Thrombophilia / drug therapy
  • Thrombophilia / immunology
  • Thrombophilia / physiopathology*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Methylprednisolone Hemisuccinate
  • mepolizumab
  • Prednisone